Prescription drug · NDA AUTHORIZED GENERIC
Enalapril Maleate NDC 68682-710
Enalapril maleate 2.5 mg/1 · Tablet · Oral · OCEANSIDE PHARMACEUTICALS
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68682-710-01 | 68682071001 | 100 TABLET in 1 BOTTLE (68682-710-01)Marketed from Jul 26, 1988 | |
| 68682-710-10 | 68682071010 | 1000 TABLET in 1 BOTTLE (68682-710-10)Marketed from Jul 26, 1988 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Enalapril Maleate
- Generic name (nonproprietary)
- enalapril maleate
- Active ingredients
- Enalapril maleate — 2.5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- OCEANSIDE PHARMACEUTICALS
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 018998
- Marketing start
- Listing expires
- Other FDA classes
- Angiotensin-converting Enzyme Inhibitors (Mechanism)Decreased Blood Pressure (Physiologic effect)
- Identifiers
- Product ID 68682-710_6771388d-89b3-43ec-b69e-9cebeaa2a00aSPL ID 6771388d-89b3-43ec-b69e-9cebeaa2a00aSPL set ID ebd2a62d-a704-4f8a-a104-749a5296502fRxCUI 858804, 858810, 858813, 858817UNII 9O25354EPJ
- Pharmacologic class
- Angiotensin Converting Enzyme Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468682071001followed by a unit qualifier and the quantityPackage 68682-0710-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Hypertension Enalapril Maleate Tablets are indicated for the treatment of hypertension. Enalapril Maleate Tablets are effective alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. The blood pressure lowering effects of Enalapril Maleate Tablets and thiazides are approximately additive. Heart Failure Enalapril Maleate Tablets are indicated for the treatment of symptomatic congestive heart failure, usually in combination with diuretics and digitalis. In these patients Enalapril Maleate Tablets improve symptoms, increases survival, and decreases the frequency of hospitalization (see CLINICAL PHARMACOLOGY, Heart Failure, Mortality…
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 018998
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Enalapril Maleate | Enalapril maleate 10 mg/1 | TabletOral | Proficient Rx LP | 71205-075 |
| Vasotecenalapril maleate | Enalapril maleate 2.5 mg/1 | TabletOral | Bausch Health US LLC | 0187-0140 |
| Vasotecenalapril maleate | Enalapril maleate 5 mg/1 | TabletOral | Bausch Health US LLC | 0187-0141 |
| Vasotecenalapril maleate | Enalapril maleate 10 mg/1 | TabletOral | Bausch Health US LLC | 0187-0142 |
| Enalapril Maleate | Enalapril maleate 5 mg/1 | TabletOral | OCEANSIDE PHARMACEUTICALS | 68682-711 |
| Enalapril Maleate | Enalapril maleate 10 mg/1 | TabletOral | OCEANSIDE PHARMACEUTICALS | 68682-712 |
| Enalapril Maleate | Enalapril maleate 20 mg/1 | TabletOral | OCEANSIDE PHARMACEUTICALS | 68682-713 |
| Vasotecenalapril maleate | Enalapril maleate 20 mg/1 | TabletOral | Bausch Health US LLC | 0187-0143 |